A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology

A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology

The goal of this clinical trial is to evaluate whether an electronic patient-reported outcome measure (ePROM)-guided flexible scheduling system can improve outpatient clinic resource utilisation in patients attending dermatology outpatient clinics for routine follow-up. The main questions it aims to answer are:

• Does the intervention reduce the number of actualised outpatient visits over 12 months compared with standard fixed scheduling?
• Does the intervention group achieve higher adherence to monthly ePROM monitoring, as measured by the proportion of completed ePROM submissions?

Inclusion Criteria:

• Dermatology outpatients otherwise due for a follow-up appointment within six months.
• Ability to independently navigate and complete ePROMs.
• Ability to provide informed consent (including parental consent for minors).

Exclusion Criteria:

• Patients who require fixed or scheduled in-person visits, including those needing skin cancer surveillance, bedside procedures (e.g., liquid nitrogen therapy), surgical interventions, or routine blood tests for immunosuppressive therapy.